Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation
{{output}}
Introduction: Triple-negative breast cancer (TNBC) is a challenging subtype of breast cancer to treat because it lacks the expression of progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor recept... ...
